Extracorporeal Membrane Oxygenation (ECMO) Systems
GPTKB entity
Statements (54)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:hospital
|
| gptkbp:consists_of |
a pump
a membrane oxygenator |
| gptkbp:developed_by |
medical engineers
cardiopulmonary bypass technology |
| https://www.w3.org/2000/01/rdf-schema#label |
Extracorporeal Membrane Oxygenation (ECMO) Systems
|
| gptkbp:is_a |
permanent solution
|
| gptkbp:is_associated_with |
multidisciplinary teams
patient monitoring systems potential complications long-term follow-up care high resource utilization improved survival rates in some cases |
| gptkbp:is_considered |
a complex procedure
a last resort treatment a life-saving intervention a high-risk procedure |
| gptkbp:is_evaluated_by |
gptkb:municipality
clinical trials |
| gptkbp:is_monitored_by |
medical staff
|
| gptkbp:is_part_of |
emergency medicine
critical care medicine extracorporeal life support (ECLS) systems |
| gptkbp:is_subject_to |
ethical considerations
|
| gptkbp:is_supported_by |
advanced monitoring technologies
|
| gptkbp:is_used_for |
temporary support
temporary respiratory support providing cardiac and respiratory support reversing hypercapnia reversing hypoxia supporting organ function temporary circulatory support |
| gptkbp:is_used_in |
research studies
intensive care units pediatric patients trauma cases adult patients cardiac surgery neonatal patients pulmonary surgery sepsis management |
| gptkbp:performed_by |
in hospitals
under general anesthesia |
| gptkbp:receives_funding_from |
healthcare systems
|
| gptkbp:regulates |
health authorities
|
| gptkbp:requires |
specialized training for operators
anticoagulation therapy |
| gptkbp:suitable_for |
patients with certain contraindications
|
| gptkbp:supports |
patients awaiting lung transplantation
patients with COVID-19 |
| gptkbp:treatment |
cardiogenic shock
severe respiratory failure |
| gptkbp:bfsParent |
gptkb:Xenios_AG
|
| gptkbp:bfsLayer |
6
|